News

Show
news from

OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board

Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer

Resolution Therapeutics appoints Dr. Amir Hefni as Chief Executive Officer

OMass Therapeutics Expands Leadership Team with Two New Appointments

Purespring Therapeutics appoints Sachin Kelkar as CFO following appointment of Julian Hanak as CEO

Resolution Therapeutics Strengthens its Executive Team with the Appointment of Simon Ramsden as Chief Financial Officer

Load more

Search